Ledger.Open graph →
SEC Form D · filed May 13, 2014

Lysosomal Therapeutics, Inc

Offering
$4.8M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Lukasz Gottwald · El Segundo, CAExec · Director22Nw Fund GP, LLC · Seattle, WAExec · Director22Nw, LP · Seattle, WAExec · DirectorDavid Bree · GEORGETOWN, GRAND CAYMAN, Cayman IslandsExec · DirectorDimitri Krainc · Cambridge, MADirectorHenri Termeer · Cambridge, MADirectorPeter Wirth · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗